HemCon Medical Technologies, Inc. GuardIVa®Antimicrobial Hemostatic IV Dressing Obtains Additional FDA Clearance and HCPCS Reimbursement Codes
9/4/2012 10:11:51 AM
PORTLAND, Ore.--(BUSINESS WIRE)--HemCon Medical Technologies (“HemCon”), a leading global developer of advanced medical technologies and products, announced receiving an additional U.S. regulatory clearance for the antimicrobial hemostatic IV dressing GuardIVa®, that is part of its European subsidiary product portfolio. GuardIVa® Antimicrobial Hemostatic IV Dressing is an adjunct to infection control measures by providing sustained IV site protection. The dressing is a flexible, absorptive sponge disk that can be easily placed around catheters to absorb exudate, cover and protect sites such as central venous catheters (CVC) and peripherally inserted central catheters (PICC).
comments powered by